Interstitial nephritis medical therapy
|
Interstitial nephritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Interstitial nephritis medical therapy On the Web |
|
American Roentgen Ray Society Images of Interstitial nephritis medical therapy |
|
Risk calculators and risk factors for Interstitial nephritis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohsen Basiri M.D.
Overview
The mainstay of treatment for TIN is discontinuation of potentially offending agent, as well as beginig supportive care. The majority of patients involved with drug-induced AIN, improve spontaneously; however, renal function may not return to previous condition.
No additional measures is needed among patients with minimal rise in the serum creatinine or those who show betterment after
discontinuation of offending agent; otherwise if renal failure persists after removing the culprit drug, obtaining a renal biopsy and attempt glucocorticoids therapy for patients with biopsy-confirmed AIN must be considered.
Medical Therapy
- Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
- Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
- Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
- Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].